Log in or Sign up for Free to view tailored content for your specialty!
Infection News
5 stories you may have missed in May
Healio Gastroenterology and Liver Disease has compiled a list of some of the top stories we reported in May.
Few ID physicians screen patients for asymptomatic C. difficile
Infectious disease physicians in the United States do not commonly screen patients for asymptomatic carriage of Clostridioides difficile, according to results from a nationwide survey.
Log in or Sign up for Free to view tailored content for your specialty!
Gilead Canada awards 11 grants to HCV micro-elimination programs
Gilead Sciences Canada awarded a series of HCV Micro-Elimination Grants to 11 organizations focused on identifying individuals with hepatitis C in high-risk hard-to-reach populations throughout Canada and linking them to care, according to a press release.
Common polymorphism responsible for HCV genotype 3 resistance to Sovaldi
Researchers identified a common polymorphism and a rare variant combination in hepatitis C genotype 3 that are responsible for a reduced response to Sovaldi, according to a study published in Gastroenterology.
More than 800,000 cholera vaccines to be given in Congo, WHO says
WHO announced today that it has partnered with the Democratic Republic of the Congo, or DRC, Ministry of Health to provide more than 800,000 people with cholera immunizations. Gavi, the Vaccine Alliance, will fund the initiative, which will be implemented in North Kivu, in the eastern part of the DRC.
Probiotics: An Unproven Answer to Prevent C. difficile Infection
Although guidelines do not recommend probiotics for the prevention of Clostridioides difficile infection, or CDI, researchers continue to study them as a potential solution.
Old-Fashioned Hand Washing Beats Probiotics Every Day for Preventing C. diff
Almost all gastroenterologists, no matter their expertise, have become quasi-experts in treating patients with Clostridioides difficile infection (CDI) because it is such a common malady, especially in individuals with inflammatory bowel disease (IBD).
FMT safe, effective in patients with IBD, C. diff infection
SAN DIEGO — Results from the ICON study presented at DDW demonstrated that fecal microbiota transplantation was safe and effective in patients with inflammatory bowel disease and Clostridioides difficile infection.
TNF inhibitor use prior to IBD surgery does not increase postoperative infection risks
SAN DIEGO — Preoperative use of TNF inhibitors in patients with Crohn’s disease and ulcerative colitis did not increase the risk for any postoperative infections or any postoperative surgical site infections, according to results of the PUCCINI trial presented at Digestive Disease Week.
Healio to report live from DDW 2019
SAN DIEGO — Over the next four days, the gastroenterology community will convene in the San Diego Convention Center for Digestive Disease Week 2019, the specialty’s largest scientific conference.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read